FDA Inspection 1279984 — Pfizer Inc.
The FDA completed an inspection of Pfizer Inc. on Aug 22, 2025 in San Diego, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 22, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- San Diego, CA (United States)
Additional Details
Sponsor, Contract Research Organization